Lonza plots $935M in capacity upgrades in Europe and U.S., plans to add 550 jobs over next 3 years | Fierce Pharma
Lonza set to manufacture coronavirus drug for Humanigen | S-GE
ISPE Announces Leaders from Health Canada, AltruBio, AstraZeneca, Gilead, Lonza, Lyndra, and More to Speak at the 2023 ISPE Annual Meeting & Expo | ISPE | International Society for Pharmaceutical Engineering
Lonza Group - Wikipedia
Lonza Introduces the New CytoSMART™ 2 System for Live Cell Imaging | World Pharma Today
Lonza opens US lab as part of early development services expansion
Lonza Group - Today, we welcome Pierre-Alain Ruffieux as... | Facebook
MilliporeSigma Announces Acquisition of MAST® Platform from Lonza, a Leading Automated Bioreactor Sampling System to Advance BioProcessing Capabilities
Lonza chemicals for agriculture - NFC label technology | Authena
Pharma giant Lonza begins work on another expansion at Pease campus - NH Business Review
Touchlight on LinkedIn: #mrna #biotech #lifesciences #biotechnews #dna #cdmo
Lonza
Grand Opening of Kodiak Sciences' Purpose-Built Bioconjugation Facility to...
Lonza expands early-development services with new Cambridge lab - Medical Design Sourcing
Lonza Optimizes Operations for the Digital Age | Rockwell Automation
Expansion of Lonza's Automated Robotic Solution for Endotoxin Testing Automates Sustainable Recombinant Factor C Assay | Lab Manager
Lonza's CEO makes sharp exit
SEC Filing - bluebird bio, Inc.
LONZA Archives - Paperless Lab Academy
Lonza breaks ground for Pease facility with new partnership and new leadership - NH Business Review
About Us | Lonza
We are expanding our drug product manufacturing network in Switzerland. This will include the installation of a new aseptic fill and finish line in Stein... | By Lonza Group | Facebook
Lonza Case Study | ProSymmetry
Lonza to Sell Specialty Ingredients Division for $4.7 Billion, Pivot to Pharma | BioSpace
